top of page


Singapore: The World's Leading Experiment in Engineered Healthspan
How policy, urban design and prevention are reshaping the way a nation ages.
When National Geographic Fellow Dan Buettner described Singapore as an "Engineered Blue Zone" in 2023, it challenged the long-held belief that exceptional health and longevity are largely the product of culture, geography or genetics.
Singapore offers a different model. Its success has been shaped through deliberate policy, long-term planning and sustained investment in population
6 min read


Where Capital Meets Longevity: Insights Ahead of the LONGEVITY INVESTORS CONFERENCE in Gstaad
The field has moved fast. Not long ago longevity was treated as a curiosity; now Longevity's a real investment category, on track to reach $67B by 2035. That shift is the thing worth paying attention to. The good companies aren't selling immortality. They're going after healthspan, treating aging as a root cause, and measuring themselves against clinical results.
6 min read


The Longevity Tech Race: Why So Many Expensive Technologies End Up Gathering Dust
One of the most common frustrations I hear from leaders of luxury wellness resorts, longevity clinics and preventative health destinations is: "We bought all this expensive longevity technology…but we’re still waiting for the return." Ironically, many of these same businesses are also using that very technology as their primary differentiator.
Hyperbaric oxygen chambers, red light therapy beds, cryotherapy machines, advanced body composition scanners, AI-powered diagnostics…
5 min read
bottom of page




